Effect of erythropoietin-stimulating agent use on belzutifan antitumor activity in patients with VHL disease–associated renal cell carcinoma: Post hoc analysis of the LITESPARK-004 study
Maughan, Benjamin L., Srinivasan, Ramaprasad, Iliopoulos, Othon, Bundsbæk Bøndergaard Iversen, Ane, Narayan, Vivek, Oudard, Stephane, Else, Tobias, Maranchie, Jodi K., Beckermann, Katy, Fu, Wei, Perini, Rodolfo F., Liu, Yanfang, Linehan, W. Marston, Jonasch, Eric
Published in Journal of clinical oncology (01.02.2024)
Published in Journal of clinical oncology (01.02.2024)
Get full text
Journal Article
Belzutifan treatment for von Hippel-Lindau (VHL) disease–associated central nervous system (CNS) hemangioblastomas (HBs) in the phase 2 LITESPARK-004 study
Iliopoulos, Othon, Bundsbæk Bøndergaard Iversen, Ane, Beckermann, Katy, Narayan, Vivek, Maughan, Benjamin L., Oudard, Stephane, Else, Tobias, Maranchie, Jodi K., Fu, Wei, Perini, Rodolfo F., Liu, Yanfang, Linehan, W. Marston, Srinivasan, Ramaprasad, Jonasch, Eric
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Oral Hypoxia-Inducible Factor 2α Inhibitor Belzutifan in Ocular von Hippel-Lindau Disease
Wiley, Henry E., Srinivasan, Ramaprasad, Maranchie, Jodi K., Chhablani, Jay, Iversen, Ane Bundsbæk Bøndergaard, Kruse, Anders, Jonasch, Eric, Gombos, Dan S., Else, Tobias, Demirci, Hakan, Maughan, Benjamin L., Hartnett, M. Elizabeth, Coleman, Hanna R., Fu, Wei, Perini, Rodolfo F., Liu, Yanfang, Linehan, W. Marston, Chew, Emily Y., Welsh, Sarah, Thavikulwat, Alisa T., Keenan, Tiarnan D.L., Bellur, Sunil, Mac, Lisa, Cukras, Catherine A.
Published in Ophthalmology (Rochester, Minn.) (01.11.2024)
Published in Ophthalmology (Rochester, Minn.) (01.11.2024)
Get full text
Journal Article
Oral Hypoxia-Inducible Factor 2α Inhibitor Belzutifan in Ocular von Hippel-Lindau Disease: Subgroup Analysis of the Single-Arm Phase 2 LITESPARK-004 Study
Wiley, Henry E, Srinivasan, Ramaprasad, Maranchie, Jodi K, Chhablani, Jay, Iversen, Ane Bundsbæk Bøndergaard, Kruse, Anders, Jonasch, Eric, Gombos, Dan S, Else, Tobias, Demirci, Hakan, Maughan, Benjamin L, Hartnett, M Elizabeth, Coleman, Hanna R, Fu, Wei, Perini, Rodolfo F, Liu, Yanfang, Linehan, W Marston, Chew, Emily Y
Published in Ophthalmology (Rochester, Minn.) (01.11.2024)
Published in Ophthalmology (Rochester, Minn.) (01.11.2024)
Get full text
Journal Article
LITESPARK-004 (MK-6482-004) phase 2 study of belzutifan, an oral hypoxia-inducible factor 2α inhibitor (HIF-2α), for von Hippel-Lindau (VHL) disease: Update with more than two years of follow-up data
Jonasch, Eric, Iliopoulos, Othon, Rathmell, Wendy Kimryn, Narayan, Vivek, Maughan, Benjamin L., Oudard, Stephane, Else, Tobias, Maranchie, Jodi K., Welsh, Sarah Joanne, Bundsbæk Bøndergaard Iversen, Ane, Roy, Ananya, Liu, Yanfang, Perini, Rodolfo F., Linehan, W. Marston, Srinivasan, Ramaprasad
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Oral HIF-2α Inhibitor Belzutifan in Ocular von Hippel-Lindau Disease: Subgroup Analysis of the Single-Arm Phase 2 LITESPARK-004 Study
Wiley, Henry E, Srinivasan, Ramaprasad, Maranchie, Jodi K, Chhablani, Jay, Bøndergaard Iversen, Ane Bundsbæk, Kruse, Anders, Jonasch, Eric, Gombos, Dan S, Else, Tobias, Demirci, Hakan, Maughan, Benjamin L, Hartnett, M Elizabeth, Coleman, Hanna R, Fu, Wei, Perini, Rodolfo F, Liu, Yanfang, Linehan, W Marston, Chew, Emily Y
Published in Ophthalmology (Rochester, Minn.) (05.06.2024)
Get full text
Published in Ophthalmology (Rochester, Minn.) (05.06.2024)
Journal Article